the line that they'll be able to replace those sales and bring the firm back to growth? [Morningstar analyst] Damien Conover , who covers Pfizer, thinks that the answer to that question is yes. He sees a lot of candidates that are either
David Risinger – Morgan Stanley Jami Rubin – Goldman Sachs Seamus Fernandez – Leerink Swann Marc Goodman – UBS Damien Conover – Morningstar David Risinger – Morgan Stanley Presentation Draft version. An edited version will be posted soon
Linda Gross $3.35M. J&J faces 4,000 lawsuits over the product in the U.S., although Morningstar analyst Damien Conover reckons J&J should be able to withstand any further penalties. Post your comment!
JP Morgan Marc Goodman - UBS Mark J. Schoenebaum - ISI Group Alex Arfaei - BMO Capital Markets Andrew Baum - Citi Damien Conover - Morningstar Presentation Operator Good day everyone and welcome to Merck’s fourth quarter 2012 earnings conference
Damien Conover : I am Damien Conover , director of pharmaceutical research at Morningstar. I'm ..... Thanks, Dave, and thanks everyone for joining me. I'm Damien Conover , director of pharmaceutical research at Morningstar. Thank
at is the pharmaceutical industry. I am here with Damien Conover , our director of pharmaceutical research, to take a closer look. Damien, thanks for joining me today. Damien Conover : Thanks for having me, Jeremy. Glaser: So, let
Holford - Jefferies & Company, Inc., Research Division Keyur Parekh - Goldman Sachs Group Inc., Research Division Damien Conover - Morningstar Inc., Research Division Naresh Chouhan - Liberum Capital Limited, Research Division Steve Scala
market over the last year. I'm here today with Damien Conover , director of pharmaceutical research, to see if ..... so where it is. Damien, thanks for joining me. Damien Conover : Thanks for having me, Jeremy. Glaser: As a sector
Amylin ranked Number 18 in Morningstar's annual biotechnology takeout list as our view of the company's strong need for a partner was tempered by fairly disappointing pipeline prospects. Damien Conover , CFA contributed to this note.
update on the Big Pharma space, I am here today with Damien Conover ; he is our associate director of health care. Damien, thanks for joining me. Damien Conover : Thanks for having me, Jeremy. Glaser : So toward